KYLE CURRY: Open Payments
NPI 1407101405 · BIDWELL, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$968 in 55 payments from 11 companies in 2025. Trend: 2023 $325 · 2024 $500 · 2025 $968
Food & beverage: $883Education: $85
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $398 |
| Janssen Biotech, Inc. | 13 | $203 |
| Novartis Pharmaceuticals Corporation | 6 | $119 |
| Organon LLC | 3 | $56 |
| GENZYME CORPORATION | 2 | $54 |
| Incyte Corporation | 2 | $37 |
| LEO Pharma Inc. | 1 | $26 |
| UCB, Inc. | 1 | $24 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $22 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $15 |
Products named: SKYRIZI, TREMFYA, RINVOQ, COSENTYX, DUPIXENT, OPZELURA, ADBRY, Bimzelx.
Industry payments across OH — which companies pay providers there.
